Shandong Weigao Group Medical Polymer Company Stock Value
Shandong Weigao Group Medical Polymer Company Company Info
EPS Growth 5Y
-2,33%
Market Cap
HK$20,74 B
Long-Term Debt
HK$4,85 B
Quarterly earnings
08/27/2026 (E)
Dividend
HK$0,25
Dividend Yield
5,42%
Founded
1988
Industry
Country
ISIN Number
Website
Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.
HK$7,00
52.84%
Last Update: 03/28/2026
Analysts: 7
Highest Price Target HK$7,94
Average Price Target HK$7,00
Lowest Price Target HK$6,10
In the last five quarters, Shandong Weigao Group Medical Polymer Company’s Price Target has risen from HK$6,03 to HK$6,33 - a 4,98% increase. Five analysts predict that Shandong Weigao Group Medical Polymer Company’s share price will increase in the coming year, reaching HK$7,00. This would represent an increase of 52,84%.
Top growth stocks in the health care sector (5Y.)
What does Shandong Weigao Group Medical Polymer Company do?
Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, wholesale, and sale of medical devices.
Business Segments
The company divides its operations into six key segments:
Medical Device Products: This segment includes the production and sale of essential medical equipment and consumables that support clinical care, medical testing, anesthesia, and surgical procedures.
Orthopaedic Products: Focuses on the development of advanced orthopaedic...
Shandong Weigao Group Medical Polymer Company Questions and Answers
Which sectors generate sales and which are the top 3 markets?
**Medical Devices:** 45%
**Consumables:** 35%
**Orthopedic Products:** 20%
**TOP 3 Markets:**
**China:** 60%
**USA:** 20%
**Europe:** 15%
Shandong Weigao Group Medical Polymer Company Limited generates the majority of its revenue from the manufacturing and sale of medical devices and...
At which locations are the company’s products manufactured?
**Production Location:** Shandong, China
Shandong Weigao Group Medical Polymer Company Limited produces the majority of its products in the province of Shandong, China. The company has several production facilities there that specialize in the manufacturing of medical devices and polymer products....
What strategy does Shandong Weigao Group Medical Polymer Company pursue for future growth?
**Revenue Growth:** Estimated at 8-10% annually (2026, based on industry trends)
**Focus on Internationalization:** Shandong Weigao Group Medical Polymer Company Limited is increasingly focusing on expanding into international markets to promote revenue growth. This includes both entering new marke...
Which raw materials are imported and from which countries?
**Main raw materials:** Polypropylene, Polyethylene, PVC
**Countries of origin:** Saudi Arabia, USA, Germany
Shandong Weigao Group Medical Polymer Company Limited mainly imports plastics such as polypropylene, polyethylene, and PVC, which are needed for the production of medical devices and consum...
How strong is the company’s competitive advantage?
**Market share in China:** 20% (estimated 2026)
**Gross margin:** 35% (2025)
**R&D expenditure growth:** 10% (2025)
Shandong Weigao Group Medical Polymer Company Limited has a significant competitive advantage in the Chinese market for medical consumables. With an estimated market share of...
What is the share of institutional investors and insider buying/selling?
**Institutional Investor Share:** Estimated at around 35% (2026)
**Insider Buys/Sells:** No significant transactions in the last year (2026)
The institutional investor share in Shandong Weigao Group Medical Polymer Company Limited is estimated to be around 35%. This indicates a certain level of c...
What percentage market share does Shandong Weigao Group Medical Polymer Company have?
**Market share of Shandong Weigao Group:** 12% (2026, estimated)
**Top competitors and their market shares:**
1. **Johnson & Johnson:** 18%
2. **Medtronic:** 15%
3. **Becton Dickinson:** 14%
4. **Shandong Weigao Group:** 12%
5. **Smith & Nephew:** 10%
6. **Boston Scientific:** 9%
7. **Stryk...
Is Shandong Weigao Group Medical Polymer Company stock currently a good investment?
**Revenue Growth:** 8.5% (2025)
**Profit Growth:** 10.2% (2025)
**Market Share in China:** 20% (2025)
Shandong Weigao Group Medical Polymer Company Limited recorded solid revenue growth of 8.5% and profit growth of 10.2% in 2025. These growth rates indicate a healthy business development supported...
Does Shandong Weigao Group Medical Polymer Company pay a dividend – and how reliable is the payout?
**Dividend Yield:** 2.5% (estimated for 2026)
**Dividend History:** Steady payouts over the last 5 years
Shandong Weigao Group Medical Polymer Company Limited has regularly distributed dividends in recent years. The dividend yield is estimated to be around 2.5% for 2026, based on past payout patt...
